# Chronic Inflammation: Causes and Morphologic Features


## Key Takeaways

- Chronic inflammation is characterized by persistent injury, immune activation, and attempted repair, differing from acute inflammation in its prolonged duration (weeks to months) and a cellular infiltrate dominated by macrophages and lymphocytes, rather than neutrophils.
- The primary etiologies of chronic inflammation include persistent infections (e.g., mycobacteria, fungi), prolonged exposure to non-degradable foreign material (e.g., implants, suture fragments), and autoimmune responses where self-antigens continuously stimulate the immune system.
- Morphologically, chronic inflammation presents as nonspecific patterns (diffuse infiltrates of lymphocytes, plasma cells, macrophages with fibrosis), granulomatous inflammation (epithelioid macrophages, multinucleated giant cells, often with caseous or non-caseous necrosis), or predominantly lymphocytic infiltrates, each suggesting different underlying causes.
- Diagnostic differentiation relies on histopathology to identify the dominant cell type and pattern, often supplemented by special stains (e.g., Ziehl-Neelsen for mycobacteria, Gomori methenamine silver for fungi), polarizing microscopy for foreign material, and immunohistochemistry (e.g., CD3 for T cells, CD20 for B cells) to distinguish reactive from neoplastic processes.
- Tissue consequences of chronic inflammation include fibrosis, parenchymal atrophy, angiogenesis, and an increased risk of neoplasia, driven by mediators like transforming growth factor-beta and sustained activation of pathways such as NF-kappaB.
- Systemic effects can manifest as fever, weight loss, anemia of chronic disease, and alterations in acute phase proteins, with complications arising from uncontrolled tissue destruction, aberrant repair, immune dysregulation, or neoplastic transformation.

---

Chronic inflammation is a prolonged tissue response in which injury, immune activation, and attempted repair proceed simultaneously. It differs from acute inflammation in duration, cellular composition, and tissue consequences. This article explains the causes of chronic inflammation, the cellular players that sustain it, and the morphologic patterns a pathologist can recognize in biopsy and necropsy material. It is written for veterinary students who already understand basic immunology and acute inflammatory mechanisms and who now need a framework for interpreting chronic inflammatory lesions across species.

The clinical question this article answers is direct: when a histopathology report describes "chronic inflammation," what does that diagnosis imply about the inciting cause, the host response, and the expected tissue damage? The answer requires integrating knowledge of lymphocyte and macrophage biology, cytokine signaling, and the limited repertoire of tissue responses available to the body. The sections that follow build from the cellular and molecular basis of chronic inflammation to the gross and histologic patterns used in diagnostic practice.

## At a Glance

| Parameter | Key Information |
|---|---|
| Defining duration | Persistent inflammation lasting weeks to months, often with concurrent tissue repair |
| Dominant cell types | Macrophages, lymphocytes, plasma cells, eosinophils and neutrophils in specific variants |
| Core mediators | Interferon-gamma, tumor necrosis factor, interleukin-6, transforming growth factor-beta |
| Common causes | Persistent infection, autoimmune responses, foreign material, unresolved acute inflammation |
| Granulomatous pattern | Epithelioid macrophages with or without multinucleate giant cells, suggests specific agents or foreign bodies |
| Lymphocytic pattern | Dense or diffuse small lymphocytes, typical of viral infection, autoimmunity, and chronic antigen exposure |
| Tissue consequences | Fibrosis, parenchymal atrophy, angiogenesis, and sometimes neoplasia risk |
| Diagnostic approach | Pattern recognition on histology, supported by culture, serology, or molecular testing |

## Causes of Chronic Inflammation

Chronic inflammation arises through three principal routes. The first is persistent infection. Microorganisms that resist acute neutrophil killing, such as mycobacteria, fungi, and certain intracellular bacteria, continue to stimulate the immune system for extended periods. The second route is prolonged exposure to nondegradable foreign material, including surgical implants, plant material, silica, and suture fragments. The third route is autoimmunity, in which self-antigens provide a continuous stimulus for lymphocyte activation. In each case, the shared feature is an inciting agent that the host cannot eliminate quickly, so the immune response shifts from the neutrophil-dominated acute pattern to a macrophage and lymphocyte-dominated chronic pattern.

The molecular switch from acute to chronic inflammation involves several cytokine pathways. Interleukin-6 is a multifunctional cytokine that regulates the immune response, hematopoiesis, and the acute phase response, and its deregulation is implicated in autoimmune disease and chronic inflammatory proliferative conditions such as rheumatoid arthritis and psoriasis. T cells, particularly CD4-positive helper subsets, orchestrate the chronic response. The traditional view held that Th1 cells drove chronic inflammation through interferon-gamma, but more recent work in experimental autoimmune encephalomyelitis and multiple sclerosis has shown that Th17 cells and gamma-delta T cells that secrete interleukin-17 also play pathogenic roles in autoimmune and chronic inflammatory conditions. These pathways converge on macrophage activation, creating a self-sustaining cycle of cytokine release and further leukocyte recruitment.

## Cellular Components of the Chronic Infiltrate

### Macrophages

Macrophages are the sentinel cells of chronic inflammation. They derive from circulating monocytes that emigrate into tissue and differentiate, and they persist for long periods. Their functions include phagocytosis, antigen presentation, and secretion of cytokines and growth factors. Activated macrophages can assume different phenotypes. Classically activated macrophages produce pro-inflammatory cytokines and kill intracellular pathogens. Alternatively activated macrophages promote tissue repair and fibrosis. In histologic sections, activated macrophages appear larger, with more abundant eosinophilic cytoplasm, and may form epithelioid cells.

### Lymphocytes

Lymphocytes provide specificity and memory to the chronic inflammatory response. B cells differentiate into plasma cells that produce antibody. T cells, including CD4-positive helper cells and CD8-positive cytotoxic cells, recognize antigen and secrete cytokines that recruit and activate macrophages. The balance of T cell subsets shapes the character of the inflammation. Regulatory T cells suppress effector responses and limit tissue damage, while effector T cells sustain the response. In autoimmune disease, the failure of regulatory mechanisms allows self-reactive T cells to persist and cause continuous injury.

### Plasma Cells and Other Leukocytes

Plasma cells are abundant in chronic inflammatory sites where antibody production is prominent, such as the intestinal lamina propria in inflammatory bowel disease and the mammary gland in chronic mastitis. Eosinophils appear when the stimulus involves allergic responses or parasitic infection. Their presence in the esophagus, for example, defines eosinophilic esophagitis as a chronic, immune-mediated disease characterized by eosinophil-predominant inflammation. Neutrophils may persist in chronic inflammation when the inciting agent continues to activate the complement system or when tissue necrosis provides ongoing chemotactic stimuli.

## Morphologic Patterns of Chronic Inflammation

### Nonspecific Chronic Inflammation

The most common pattern is a diffuse or perivascular infiltrate of lymphocytes, plasma cells, and macrophages, often accompanied by fibrosis. This pattern is nonspecific in the sense that many different causes produce it. The pathologist describes the predominant cell type, the distribution, and the associated tissue changes. A lymphocytic infiltrate in the liver with piecemeal necrosis suggests chronic viral hepatitis. A lymphoplasmacytic infiltrate in the kidney with interstitial fibrosis suggests chronic nephritis. The pattern alone rarely identifies the cause, but it narrows the differential diagnosis.

### Granulomatous Inflammation

Granulomatous inflammation is a distinctive pattern in which macrophages transform into epithelioid cells and may fuse into multinucleate giant cells. A granuloma is a compact collection of these cells, often surrounded by a rim of lymphocytes and fibrosis. This pattern develops when the inciting agent is resistant to degradation, such as mycobacterial cell walls, fungal organizms, or foreign material. The presence of caseous necrosis within a granuloma strongly suggests mycobacterial infection. Noncaseating granulomas occur with fungal infection, sarcoidosis-like reactions, and foreign bodies. The Davis-Thompson Foundation provides educational pathology collections and case material that illustrate these patterns across species, and the MSD Veterinary Manual offers species-specific guidance on diseases that produce granulomatous inflammation.

### Fibrosis and Tissue Remodelling

Chronic inflammation almost always includes some degree of fibrosis, because the same macrophages that sustain inflammation also secrete transforming growth factor-beta and platelet-derived growth factor, which activate fibroblasts. The tyrosine kinase inhibitor nintedanib has been shown to reduce fibrosis in experimental models of lung fibrosis by blocking signaling through platelet-derived growth factor receptors and transforming growth factor-beta pathways, confirming the central role of these mediators in chronic inflammatory tissue remodelling. Fibrosis can be reversible in early stages but becomes irreversible once collagen is cross-linked and parenchymal architecture is lost.

## Systemic Effects and Complications

Chronic inflammation is not confined to the local tissue. Systemic effects include fever, weight loss, anemia of chronic disease, and alterations in serum protein levels. Interleukin-6 drives hepatic synthesis of acute phase proteins, and sustained elevation of this cytokine contributes to the systemic manifestations of autoimmune disease. Chronic inflammation also creates a microenvironment permissive for neoplasia. The nuclear factor-kappa B pathway, which regulates expression of hundreds of genes involved in inflammation and cell survival, is frequently misregulated in diseases associated with chronic inflammation and cancer. Mutations in components of this pathway have been identified in several human diseases, and similar mechanisms are presumed to operate in veterinary patients.

## Diagnostic Approach to Chronic Inflammation

The classification of a chronic inflammatory process begins with routine histopathology. H&E-stained sections allow the pathologist to identify the dominant cell population, its distribution, and the character of the accompanying stromal response. This initial assessment determines whether the lesion fits a nonspecific pattern, a granulomatous pattern, or a predominantly lymphocytic pattern, and it directs the subsequent diagnostic workup.

The decision tree below summarizes the sequential classification of chronic inflammation based on cellular infiltrate and tissue response.

| Histologic finding | Pattern | Primary differentials | Ancillary testing |
|---|---|---|---|
| Mixed mononuclear cells, no organization, variable fibrosis | Nonspecific chronic inflammation | Persistent infection, foreign body, autoimmune disease, chronic injury | Culture, serology, polarising microscopy |
| Epithelioid macrophages, with or without multinucleated giant cells | Granulomatous inflammation | Mycobacteria, fungi, foreign material, idiopathic | Special stains (Ziehl-Neelsen, GMS), culture, polarising microscopy |
| Dense sheets of small lymphocytes, often perivascular or follicular | Lymphocytic inflammation | Viral infection, autoimmune disease, hypersensitivity | Serology, PCR, immunohistochemistry for T and B cell markers |
| Eosinophil-rich infiltrate with epithelial injury | Eosinophilic inflammation | Parasitism, hypersensitivity, eosinophilic gastrointestinal disease | Fecal examination, dietary trial, allergen assessment |

The first decision point is whether the infiltrate is composed predominantly of macrophages or lymphocytes. Macrophage-predominant lesions with epithelioid morphology require special stains for infectious agents before a diagnosis of idiopathic granulomatous disease is made. Lymphocyte-predominant lesions require distinction between reactive and neoplastic populations, particularly when the infiltrate is monomorphic or effaces normal architecture.

## Histochemical and Immunohistochemical Techniques

Special stains are selected based on the morphologic pattern and the suspected aetiology. For granulomatous inflammation, Ziehl-Neelsen staining detects mycobacteria, Gomori methenamine silver detects fungal organizms, and periodic acid-Schiff highlights fungal cell walls and some protozoa. Polarising microscopy identifies crystalline foreign material such as plant fibers, suture material, or urate crystals.

Immunohistochemistry adds lineage-specific information when routine stains are inconclusive. CD3 labels T lymphocytes, CD20 or Pax5 labels B lymphocytes, and MAC387 or Iba1 labels macrophages. A mixed infiltrate with both T and B cells supports a reactive process, whereas a monotypic population raises concern for lymphoma. The [Davis-Thompson Foundation veterinary pathology resources](https://www.davisthompsonfoundation.org/) provide case material and diagnostic teaching collections that illustrate these staining patterns across species.

Flow cytometry is reserved for cases where lymphoma is suspected and fresh tissue is available. It offers immunophenotyping of cell suspensions and can detect clonality when combined with PCR for antigen receptor rearrangement. These techniques are particularly useful in dogs and cats with chronic gastrointestinal or cutaneous infiltrates where the distinction between inflammatory bowel disease and alimentary lymphoma is challenging.

## Interpretation of the Granulomatous Response

Granulomatous inflammation represents a specific macrophage response to persistent stimuli that resist degradation. The organization of macrophages into epithelioid aggregates, often with multinucleated giant cells, indicates chronic antigenic stimulation. The presence of caseous necrosis suggests mycobacterial infection, while suppurative granulomas with neutrophils and macrophages are typical of fungal infections or foreign bodies.

The distribution of granulomas provides diagnostic information. Perivascular granulomas suggest immune-mediated disease. Granulomas centerd on lymphatic vessels or lymph nodes raise concern for infectious agents with lymphatic spread. Military granulomas distributed randomly throughout an organ are typical of hematogenous dissemination.

When special stains and culture fail to identify an organizm, the diagnosis of idiopathic granulomatous disease is made by exclusion. This occurs in conditions such as feline idiopathic granulomatous disease and canine sterile granulomatous dermatitis. In these cases, the [MSD Veterinary Manual professional edition](https://www.msdvetmanual.com/) provides species-specific guidance on clinical presentation and management options.

## Monitoring and Documentation of Chronic Inflammation

Serial biopsy is the most reliable method for monitoring the progression or resolution of chronic inflammation. Repeat biopsy is indicated when clinical signs worsen despite treatment, when a new lesion appears, or when the initial sample was small or poorly representative. The biopsy report should document the dominant cell type, the distribution of the infiltrate, the degree of fibrosis, and the presence or absence of tissue necrosis.

Clinical monitoring parameters vary by organ system. For chronic gastrointestinal inflammation, serial measurement of serum albumin, cobalamin, and folate tracks absorptive function. For chronic kidney disease with interstitial nephritis, serial creatinine and symmetric dimethylarginine measurements monitor progression. For chronic hepatitis, bile acids and liver enzyme activities provide indirect evidence of ongoing inflammation and hepatocellular injury.

Imaging findings complement histopathology. Ultrasonographic assessment of intestinal wall thickness and layering, thoracic radiography for pulmonary infiltrates, and magnetic resonance imaging for central nervous system inflammation all provide macroscopic evidence of disease distribution. These findings are documented alongside histopathology in the medical record to establish a baseline for future comparison.

## Species and System Considerations

The diagnostic approach must be adjusted for species, production system, and available equipment. In food animals, the cost of diagnostic testing and the potential for herd-level disease influence the workup. Granulomatous lesions in cattle and small ruminants warrant immediate consideration of mycobacterial infection, and the [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) define surveillance and reporting requirements that may apply.

In horses, chronic inflammatory airway disease and equine asthma syndrome are diagnosed by bronchoalveolar lavage cytology instead of biopsy. The cytologic pattern, whether neutrophilic, mastocytic, or eosinophilic, guides therapy. In exotic and wildlife species, sample size constraints often limit the diagnostic workup, and histopathology may be the only test available.

The availability of immunohistochemistry and molecular diagnostics varies between referral laboratories and practice settings. When these tests are unavailable, the pathologist must rely on routine stains and morphologic features alone. This limitation should be stated explicitly in the biopsy report so that the clinician understands the diagnostic certainty of the interpretation.

The distinction between reactive and neoplastic lymphocytic infiltrates is the most consequential decision in chronic inflammation diagnostics. When immunohistochemistry is unavailable, morphologic features such as cellular monomorphism, nuclear atypia, and transmural infiltration support neoplasia. In equivocal cases, a second opinion from a veterinary pathologist with access to advanced diagnostic tools is appropriate.

## Recognized Complications and Early Detection

Chronic inflammation fails most often through one of four mechanisms: uncontrolled tissue destruction, aberrant repair, immune dysregulation, or neoplastic transformation. Each has identifiable early markers.

Progressive fibrosis is the most common failure of resolution. In the lung, repeated macrophage and lymphocyte recruitment drives fibroblast proliferation and myofibroblast differentiation through transforming growth factor beta and platelet-derived growth factor signaling. Early detection relies on serial functional assessment instead of histology, since fibrosis is often advanced before architectural distortion is visible. Serial thoracic radiography, ultrasonographic measurement of organ dimensions, and biochemical markers such as liver enzyme trends in hepatic fibrosis provide the earliest practical evidence. The tyrosine kinase inhibitor nintedanib, which blocks platelet-derived growth factor receptor signaling, reduces fibrosis in experimental models, confirming that this pathway is a tractable therapeutic target when identified early ([nintedanib activity in experimental lung fibrosis](https://pubmed.ncbi.nlm.nih.gov/24556663/)).

Immune dysregulation presents as either uncontrolled effector activity or loss of self-tolerance. Persistent antigen stimulation with concurrent regulatory T cell failure permits autoreactive clones to expand. In experimental autoimmune encephalomyelitis, the animal model for multiple sclerosis, both Th1 and Th17 CD4+ T cells mediate pathology, and IL-17-secreting gamma delta T cells contribute to chronic tissue injury ([T cell subsets in autoimmune inflammation](https://pubmed.ncbi.nlm.nih.gov/20682002/)). In veterinary patients, early detection of dysregulation relies on recognizing a shift from localized to systemic signs: new joint involvement, proteinuria, or rising autoantibody titres in a patient with established chronic inflammation should prompt reassessment of the driving antigen.

Neoplastic transformation is the most serious complication. Chronic inflammation generates sustained NF-kappaB activation, which promotes cell proliferation and survival while suppressing apoptosis. Mutations in NF-kappaB pathway components, including REL amplification and NEMO mutations, are documented in inflammation-associated cancers ([NF-kappaB mutations in inflammatory disease](https://pubmed.ncbi.nlm.nih.gov/17072331/)). Early detection requires a low threshold for biopsy of any chronic lesion that changes character, fails to respond to appropriate therapy, or develops new mass effect.

## Common Errors and Corrective Actions

| Observation | Likely cause | Discriminating check |
|---|---|---|
| Infiltrate reported as "chronic" with no dominant cell type | Descriptive diagnosis without pattern recognition | Re-examine for granuloma organization, lymphoid follicle formation, or eosinophil predominance |
| Granuloma suspected but no organizm found | Non-infectious cause, sampling error, or organizm below detection | Special stains for fungi and acid-fast bacteria, culture, PCR on fresh tissue |
| Fibrosis interpreted as end-stage with no active inflammation | Sampling of a fibrotic zone within an active lesion | Biopsy at the interface between fibrotic and cellular areas |
| Lymphocytic infiltrate assumed to be autoimmune | Chronic infection or foreign body with similar histology | Search for the inciting agent, correlate with culture and serology |
| Eosinophil-rich infiltrate attributed solely to parasitism | Allergic or immune-mediated disease overlooked | Dietary history, drug exposure, and tissue location, eosinophilic esophagitis in humans is antigen-driven and histologically identical to many veterinary cases ([eosinophilic esophagitis consensus recommendations](https://pubmed.ncbi.nlm.nih.gov/21477849/)) |

The most common student error is equating chronic inflammation with lymphocytic infiltration alone. Chronic infiltrates are dynamic mixtures, and the dominant cell type reflects the inciting agent, the tissue microenvironment, and the duration of the response. A second frequent error is overinterpreting fibrosis as irreversible. Fibrosis is often partially reversible if the inciting stimulus is removed, and the presence of active inflammation at the fibrotic margin predicts a better response to treatment.

## Limitations of Current Evidence

The evidence base for chronic inflammation is drawn heavily from human medicine and laboratory animal models, and extrapolation to veterinary species carries genuine uncertainty. Cytokine biology differs between species, and therapeutic targets validated in mice have repeatedly failed in clinical trials. The role of the intestinal microbiota in systemic inflammation is an active area of investigation. Transfer of a healthy microbiota into a transgenic Alzheimer's disease mouse model reduced amyloid pathology, glial reactivity, and cognitive impairment, and reversed abnormalities in intestinal macrophage activity and circulating inflammatory monocytes ([microbiota transfer in Alzheimer's disease model](https://pubmed.ncbi.nlm.nih.gov/31471351/)). Whether similar manipulation of the microbiome can modulate chronic inflammatory disease in veterinary patients remains unproven.

Expert opinion still differs on the threshold for classifying a lesion as granulomatous versus mixed chronic inflammation, and on the clinical significance of eosinophil-predominant infiltrates in tissues where eosinophils are normally sparse. Interleukin-6 is implicated in autoimmune disease and chronic inflammatory proliferative disease, but whether IL-6 blockade is appropriate in veterinary patients depends on species-specific evidence that is often lacking ([IL-6 in autoimmune and proliferative disease](https://pubmed.ncbi.nlm.nih.gov/12220549/)).

## Referral, Consultation, and Reporting

Referral is warranted when the diagnosis is uncertain after initial biopsy, when the lesion fails to respond to appropriate therapy, or when specialised imaging or immunohistochemistry is required. The [Davis-Thompson Foundation pathology resources](https://www.davisthompsonfoundation.org/) provide case material and diagnostic teaching collections that support interpretation of difficult lesions. Laboratory consultation is appropriate for unusual granulomatous reactions, suspected neoplasia, or when special stains exceed local capacity.

Regulatory reporting obligations vary by jurisdiction and production system. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) define notifiable diseases that may present with chronic inflammation, and the [AVMA practice resources](https://www.avma.org/resources-tools) summarize professional obligations in the United States. Clinicians must confirm local requirements before assuming a lesion has no reporting implications.

## Frequently Asked Questions

### How do I distinguish chronic active inflammation from a purely chronic infiltrate on biopsy?

The distinction rests on identifying concurrent acute and chronic features. Chronic active inflammation shows lymphocytes, plasma cells, and macrophages alongside neutrophils, often with tissue necrosis or ulceration. Purely chronic inflammation lacks the neutrophilic component and typically shows more fibrosis and fewer parenchymal changes. The clinical context matters. Persistent antigenic stimulation, such as an infected foreign body or a draining tract, frequently produces chronic active inflammation. If neutrophils dominate without an obvious cause, reconsider the differential to include recurrent antigen exposure or a defect in leukocyte function. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides species-specific guidance on interpreting inflammatory patterns in biopsy samples.

### What should I do when immunohistochemistry is unavailable for characterizing the infiltrate?

Routine hematoxylin and eosin evaluation remains the primary diagnostic tool. Assess cell morphology, distribution, and tissue architecture. Macrophages often have abundant eosinophilic cytoplasm and oval nuclei, while lymphocytes are small with scant cytoplasm and dense nuclei. Plasma cells show a perinuclear clear zone and clock-face chromatin. Special stains available in most laboratories include Giemsa for mast cells and toluidine blue for metachromatic granules. Periodic acid-Schiff staining helps identify fungal organizms and basement membrane material. The [Davis-Thompson Foundation](https://www.davisthompsonfoundation.org/) offers case-based resources that demonstrate how to characterize infiltrates using basic stains when advanced techniques are unavailable.

### How does the approach to chronic inflammation differ in food animals compared with companion animals?

Production animals present unique constraints. Cost and throughput limit advanced diagnostics, and chronic inflammation often reflects management or environmental factors instead of individual disease. Granulomatous lesions in cattle and small ruminants should prompt consideration of mycobacterial infection, which carries regulatory and zoonotic implications. Reporting requirements vary by region, and the [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) outline surveillance expectations for notifiable diseases. In companion animals, the focus shifts to immune-mediated and neoplastic differentials. Necropsy and histopathology remain the gold standard in both settings, but ante-mortem sampling and cytology may be more practical in food animal practice.

### What are the key features of granulomatous inflammation that suggest an infectious versus a non-infectious cause?

Infectious granulomas typically show central necrosis, often caseous or suppurative, with a rim of epithelioid macrophages and variable multinucleated giant cells. Fungal and mycobacterial organizms may be visible with appropriate stains. Non-infectious granulomas, such as those seen with foreign material, often contain refractile debris or polarisable material and show less necrosis. The distribution of lesions helps. Disseminated granulomas favour hematogenous spread of infection, whereas localized lesions suggest implantation or aspiration. The NF-kappaB signaling pathway regulates many genes involved in chronic inflammation, and mutations in this pathway contribute to inflammatory disease, as described in [a review of NF-kappaB pathway mutations](https://pubmed.ncbi.nlm.nih.gov/17072331/). Culture and molecular testing should accompany histopathology when infection is suspected.

### How should I document chronic inflammatory lesions in the medical record?

Record the anatomic location, gross appearance, and distribution of lesions. Describe the cellular composition of the infiltrate, the presence or absence of necrosis, fibrosis, and tissue remodelling. Note any foreign material, organizms, or mineralisation. Include the clinical history, duration of signs, and response to prior treatment. Photographs of gross lesions and representative histologic sections are valuable for teaching and for comparison with future biopsies. Document the differential diagnosis and the rationale for the final interpretation. The [AVMA practice resources](https://www.avma.org/resources-tools) provide guidance on medical record standards and professional communication that apply to pathology reporting.

### How do I explain chronic inflammation to a client whose animal has a persistent lesion?

Use clear analogies without oversimplifying. Explain that chronic inflammation is the body's prolonged response to an irritant that has not been removed, and that the tissue changes may persist even after the cause is eliminated. Describe what the biopsy showed and what it means for prognosis. If the cause is unknown, state that further testing may be needed. Avoid guaranteeing outcomes. Explain that fibrosis, or scar tissue, may remain after the inflammation resolves and can cause permanent functional change. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) offers client-facing summaries that can reinforce your explanation. Encourage questions and provide written recommendations for follow-up monitoring.

## Related Clinical & Scientific Guides

* [Hypersensitivity Reactions: Types and Mechanisms](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/hypersensitivity-reactions-types-and-mechanisms)
* [Therapeutic Decision-Making for Respiratory Infections in Cattle](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/therapeutic-decision-making-respiratory-infections-cattle)
* [Monitoring Fluid Therapy in Critically Ill Veterinary Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-fluid-therapy-critically-ill-veterinary)


## References and Further Reading

- [Eosinophilic esophagitis: updated consensus recommendations for children and adults.](https://pubmed.ncbi.nlm.nih.gov/21477849/). 2011.
- [T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.](https://pubmed.ncbi.nlm.nih.gov/20682002/). 2010.
- [IL-6 in autoimmune disease and chronic inflammatory proliferative disease.](https://pubmed.ncbi.nlm.nih.gov/12220549/). 2002.
- [Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.](https://pubmed.ncbi.nlm.nih.gov/24556663/). 2014.
- [Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.](https://pubmed.ncbi.nlm.nih.gov/31471351/). 2020.
- [Mutations in the NF-kappaB signaling pathway: implications for human disease.](https://pubmed.ncbi.nlm.nih.gov/17072331/). 2006.
- [Davis-Thompson Foundation Veterinary Pathology Resources](https://www.davisthompsonfoundation.org/). Davis-Thompson Foundation.
- [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual.
- [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association.

## Related Articles

- [Acute Inflammation: Vascular and Cellular Events](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/acute-inflammation-vascular-and-cellular-events)
- [Cell Injury Mechanisms and Morphologic Patterns](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/cell-injury-mechanisms-and-morphologic-patterns)
- [Inflammation and Tissue Healing Process](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/inflammation-and-tissue-healing-process)
- [Clinical Pathology: Hematology and Biochemistry Interpretation](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/clinical-pathology-hematology-and-biochemistry-interpretation)
- [Differential Diagnosis in Pathology: A Structured Approach](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/differential-diagnosis-in-pathology-a-structured-approach)

> This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.